American Intragastric Balloons Are Safe and Effective For Weight Reduction (Published)
The bioenteric balloon (BIB) or spatzs ballon are widely applied in the management of obesity. This is a report on the efficacy and safety of Ballon device in the first 106 cases. Patients referred for Balloon between 2015 till 2016 were evaluated retrospectively. Balloon was inserted for 6 months according to predetermined inclusion and exclusion criteria. In 106 cases, 22 cases were males (16.8%) and 84 cases were females (83.2%), mean age 33.2 (±10.44) years, mean BMI 35.9 (±4.65) kg/m2. None of the patients exhibited balloon migration or perforation. The balloon was removed upon request in 3 patients due to exaggerated intolerance (2.9%). The mean weight loss was 15.5 kg (±4.67), mean EWL 64.12% (±23.48%). The mean BMI at extraction was 29.7 kg/m2 (±4.48) with a BMI loss of 6.2 kg/m2 (±2.0). 87 patients (88.7%) achieved target EWL (32.1% of excess weight), and 87 patients lost >12.2% of their basal weight (88.7%). 70 patients achieved BMI loss >5.7 kg/m2 (71.4%). BIB and spatzs balloon achieves acceptable success with minimal complications. In further long term, prospective studies are needed to evaluate obesity related comorbidities when using such modality and to compare it to other available devices.
Keywords: American Balloon, Bioenteric Balloon, Obesity, Weight Loss, spatzs balloon
The Prevalence of Vitamin D Deficiency among Overweight and Obese Individuals (Published)
Objective: Vitamin D deficiency and obesity are widely spread and were associated with chronic diseases. The goal of our study is to evaluate the prevalence of vitamin D deficiency in obese individuals and its association with the metabolic parameter. Method:A cross sectional study of individuals attending diet center located in Taif, Saudi Arabia, conducted between October 2015 and June 2016. We included those with BMI >25 and have vitamin D level. Vitamin D ≤ 20 ng/ml was considered to be deficient. Result:A total of 148 participants were enrolled with a mean age of 36 years, mainly female and married .The mean weight was 95.9 kg, mean BMI of 37.3 Kg/m2, 94.6% were obese, and the mean vitamin D level was 15.7. Compared to those who are vitamin D sufficient ,those who are deficient were more likely to have class III obesity (p 0.891), exercise <150 min per week (p 0.453), have asthma (P 0.149), have higher mean total cholesterol level (p 0.310) and higher mean fasting blood glucose (p 0.632). Partial correlation adjusting for age, gender, exercise, diabetes, and hypertension showed non-significant negative correlation between vitamin D and BMI (r -.121, p0.202), vitamin D and cholesterol (r -.039, p 0.678) and vitamin D and blood glucose (r -.122, p 0.198).Conclusion: Non-significant negative correlation was found between BMI and vitamin D level, the average vitamin D level in overweight group was 21 ng/ml while the average in obese class 3 was 15 ng/ml.
Keywords: Obesity, Vitamin D, Weight Loss, diet
Weight Loss by Intragastric Balloon (Published)
Introduction: The bioenteric balloon (BIB) or spatzs ballon are widely applied in the management of obesity.Aim of the work: This is a report on the efficacy and safety of Ballon device in the first 101 cases.Methods: Patients referred for Balloon between 2014 till 2015 were evaluatedretrospectively. Balloon was inserted for 6 months according to predetermined inclusion and exclusion criteria. Results: In 101 cases, 17 cases were males (16.8%) and 84 cases were females (83.2%), mean age 33.2 (±10.44) years, mean BMI 35.9 (±4.65) kg/m2. None of the patients exhibitedballoon migration or perforation. The balloon was removed upon request in 3 patients dueto exaggerated intolerance (2.9%). The mean weight loss was 15.5 kg (±4.67), mean EWL 64.12% (±23.48%). The mean BMI at extraction was 29.7 kg/m2 (±4.48) with a BMI loss of 6.2 kg/m2 (±2.0). 87 patients (88.7%) achieved target EWL (32.1% of excess weight), and 87 patients lost >12.2% of their basal weight (88.7%). 70 patients achieved BMI loss >5.7 kg/m2 (71.4%). Conclusion: BIB and spatzs balloon achieves acceptable success with minimal complications. In further long term, prospective studies are needed to evaluate obesity related comorbidities when using such modality and to compare it to other available devices.
Keywords: Bioenteric Balloon, Obesity, Weight Loss, spatzs balloon
Comparison of Short-Term Outcomes between Laparoscopic Greater Curvature Plication and Laparoscopic Sleeve Gastrectomy (Published)
Background; laparoscopic sleeve gastrectomy (LSG) involves resection of a significant portion of the stomach. Laparoscopic greater curvature plication (LGCP) is a relatively new alternative procedure similar to LSG, but without the need for gastric resection.Patients and methods; one hundred patients included in our study in AL Jadria hospital in Baghdad and were assigned randomly to receive either LGCP (n = 50) [35 women and 15 men; mean age 32.1 years (19-49 years) and mean BMI 44.8 kg/m 2 (40-50 kg/m 2 )] or LSG (n = 50) [34 women and16 men; mean age 34.8 years (18-58 years) and mean BMI 46.8 kg/m 2 (41-55 kg/m 2 )] by a block randomization method. Patients were studied in terms of postoperative weight loss, and postoperative complications. Results; All procedures were completed laparoscopically. Follow-up was 24 months. The mean hospital stay was 36 h (range 24-96 h) for both groups. No intraoperative complications occurred. Postoperatively, one case of minor leak was detected after LSG and two cases of stenosis following LGCP. All patients experienced postoperative excess weight loss. Conclusion; LGCP is feasible, safe, and effective, but has an inferior weight-loss effect compared to LSG for morbidly obese patients with BMI above 40 kg/m 2 .
Keywords: Laparoscopicsleeve Gastrectomy, Stomach, Surgery, Weight Loss
Comparison of Short-Term Outcomes between Laparoscopic Greater Curvature Plication and Laparoscopic Sleeve Gastrectomy. (Published)
Background; laparoscopic sleeve gastrectomy (LSG) involves resection of a significant portion of the stomach. Laparoscopic greater curvature plication (LGCP) is a relatively new alternative procedure similar to LSG, but without the need for gastric resection.
Patients and methods; one hundred patients included in our study in AL Jadria hospital in Baghdad and were assigned randomly to receive either LGCP (n = 50) [35 women and 15 men; mean age 32.1 years (19-49 years) and mean BMI 44.8 kg/m 2 (40-50 kg/m 2 )] or LSG (n = 50) [34 women and16 men; mean age 34.8 years (18-58 years) and mean BMI 46.8 kg/m 2 (41-55 kg/m 2 )] by a block randomization method. Patients were studied in terms of postoperative weight loss, and postoperative complications. Results; All procedures were completed laparoscopically. Follow-up was 24 months. The mean hospital stay was 36 h (range 24-96 h) for both groups. No intraoperative complications occurred. Postoperatively, one case of minor leak was detected after LSG and two cases of stenosis following LGCP. All patients experienced postoperative excess weight loss. Conclusion; LGCP is feasible, safe, and effective, but has an inferior weight-loss effect compared to LSG for morbidly obese patients with BMI above 40 kg/m 2 .
Keywords: Laparoscopicsleeve Gastrectomy, Stomach, Surgery, Weight Loss
Comparison of Short-Term Outcomes between Laparoscopic Greater Curvature Plication and Laparoscopic Sleeve Gastrectomy (Published)
Background; laparoscopic sleeve gastrectomy (LSG) involves resection of a significant portion of the stomach. Laparoscopic greater curvature plication (LGCP) is a relatively new alternative procedure similar to LSG, but without the need for gastric resection. Patients and methods; one hundred patients included in our study in AL Jadria hospital in Baghdad and were assigned randomly to receive either LGCP (n = 50) [35 women and 15 men; mean age 32.1 years (19-49 years) and mean BMI 44.8 kg/m 2 (40-50 kg/m 2 )] or LSG (n = 50) [34 women and16 men; mean age 34.8 years (18-58 years) and mean BMI 46.8 kg/m 2 (41-55 kg/m 2 )] by a block randomization method. Patients were studied in terms of postoperative weight loss, and postoperative complications. Results; All procedures were completed laparoscopically. Follow-up was 24 months. The mean hospital stay was 36 h (range 24-96 h) for both groups. No intraoperative complications occurred. Postoperatively, one case of minor leak was detected after LSG and two cases of stenosis following LGCP. All patients experienced postoperative excess weight loss. Conclusion; LGCP is feasible, safe, and effective, but has an inferior weight-loss effect compared to LSG for morbidly obese patients with BMI above 40 kg/m 2 .
Keywords: Laparoscopicsleeve Gastrectomy, Stomach, Surgery, Weight Loss